跳至主要内容
临床试验/CTRI/2025/11/097242
CTRI/2025/11/097242尚未招募不适用

Unveiling host proteomic signatures in bronchoalveolar lavage fluid (BALF) of active pulmonary tuberculosis: Towards development of serum based diagnostic tools

ICMR1 个研究点 分布在 1 个国家目标入组 172 人开始时间: 2025年12月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
ICMR
入组人数
172
试验地点
1

研究概览

简要总结

This study aims to identify specific proteins in the lung fluid of patients with active pulmonary tuberculosis to help develop a simple blood-based test for early diagnosis. Lung fluid samples collected during routine bronchoscopy and blood samples from the same patients and healthy individuals will be analyzed using proteomic methods to find differences in protein levels. A few acute phase proteins showing significant changes will be selected and measured in serum using ELISA to assess their potential as diagnostic markers. The findings may help design easier and safer diagnostic tests for tuberculosis, especially useful in patients who cannot provide sputum samples or have negative sputum results.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • Patients above 18 years, with microbiologically confirmed active pulmonary tuberculosis (sputum smear, CBNAAT, or culture positive), undergoing bronchoscopy for clinical evaluation will be included.

排除标准

  • Patients with disseminated tuberculosis, extrapulmonary tuberculosis, HIV-positive individual, autoimmune diseases, malignancies, chronic inflammatory conditions, on immunosuppressive therapy, chemotherapy, chronic corticosteroids, critically ill patients unfit for bronchoscopy and pregnant/lactating women will be excluded.

研究者

发起方
ICMR
申办方类型
Government funding agency
责任方
Principal Investigator
主要研究者

Dr Krishnapriya P Shankar

KASTURBA MEDICAL COLLEGE, MANIPAL

研究点 (1)

Loading locations...

相似试验

Study to identify inflammation-related proteins in... | 临床试验